Fact Based List:
Highlights from AAM's Generic & Biosimilar Medicines Savings Report
Submitted by Patty Jamison on Tue, 10/24/2023 - 13:19
- Total Generic and Biosimilar Savings for 2022: $408 billion
- Total Generic and Biosimilar Savings for Past 10 years: more than $2.9 trillion
- Total Generic and Biosimilar Savings in Medicare for 2022: $130 Billion
- Total Generic and Biosimilar Savings in Commercial Plans for 2022: $194 Billion
- Generics represent 90% of prescriptions filled but only 17.5% of prescription drug spending
- Generics represent less than 2% of all health care spending
Source: AAM, Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022, September 6, 2023
Source URL: https://accessiblemeds.org/resources/press-releases/generic-...
Printer-friendly version
Send to friend| List Ratings: |
Lists You Might Also Be Interested In
- ACOs with highest published attributed membership totals - April 2012
- Commonwealth Fund: Percent of adults ages 19 to 64, insured all year but underinsured, 2003 to 2018
- Lisa Harst: 7 Ways Healthcare Marketers Can Use Social Video to Improve Healthcare Marketing
- AJMC: 5 Characteristics Associated with Patients Remaining in an ACO for 24 Months or More
- Health Affairs: Five Lessons From 30 Years Of Bundled Payments
Login or register to post comments
